Iron overload: An accelerator of deadly cell responses in stroke
A study has uncovered that iron orchestrates the activation of two damaging cell death pathways—ferroptosis and ...
Roche Gets FDA Approval for Acute Ischemic Stroke Drug for Adults
RHHBY's member company, Genentech, obtains FDA nod for TNKase (tenecteplase), a thrombolytic or clot-dissolving agent, for the treatment of acute ischemic stroke in adults.
Discovery of growth factor and receptor mechanism in brain could improve stroke care
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
News Medical9h
Research identifies iron as crucial driver of stroke-related cell death processes
Ischemic stroke continues to rank among the top causes of death and long-term disability globally. While advances in acute treatments like clot retrieval and thrombolysis have improved outcomes, the ...
Armed robbery in Revesby11h
New Findings Could Improve Stroke Care
Researchers at Karolinska Institutet have identified a new mechanism that may improve the treatment of ischemic stroke. The ...
BioSpace11h
Roche Continues Regulatory Run With Acute Stroke Expansion for Heart Attack Drug
According to Roche subsidiary Genentech, which announced the label expansion on Monday, TNKase is the first new drug for ...
LBCI Lebanon13h
Lebanon announces May 4 as the first phase of municipal elections: Minister
Lebanon's interior minister announced that the first phase of the municipal elections will take place on May 4. Speaking at ...
pharmaphorum14h
Roche ends the 30-year US hiatus in new stroke drugs
In 2023, Roche said it was removing TNKase for stroke from its phase 3 programmes after a readout of the TIMELESS trial, but ...